Medical Technology

@xconomy.com 3 years ago

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

@xconomy.com 3 years ago

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

@xconomy.com 4 years ago

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 4 years ago

Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic

@xconomy.com 4 years ago

ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More

@techcrunch.com 4 years ago

Google’s SMILY is reverse image search for cancer diagnosis

@xconomy.com 4 years ago

Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer

@xconomy.com 5 years ago

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

@xconomy.com 5 years ago

ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front

@xconomy.com 5 years ago

Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo

@xconomy.com 6 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

@techcrunch.com 6 years ago

Ourotech is taking the guesswork out of cancer treatment

@venturebeat.com 7 years ago

Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs

@extremetech.com 8 years ago

First cancer-killing virus finally approved by FDA